P47870 (GBRB2_HUMAN) Homo sapiens (Human)
Gamma-aminobutyric acid receptor subunit beta-2 UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
17 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus allopregnanolone |
Heteromer P14867; P18507; | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×Y4B; 2×ABU; | ||||
Assess | ||||||
Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus Zolpidem |
Heteromer P14867; P18507; | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 3×R5R; 2×ABU; | ||||
Assess | ||||||
Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus pregnenolone sulfate |
Heteromer P14867; P18507; | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 6×PTY; 1×Q3G; 1×A8W; | ||||
Assess | ||||||
Complex of GABA-A synaptic receptor with autoimmune antibody Fab115 |
Heteromer P14867; P18507; | 4×NAG; 2×NAG; 1×NAG; | ||||
Assess | ||||||
Complex of GABA-A synaptic receptor with autoimmune antibody Fab175 |
Heteromer P14867; P18507; | 3×NAG; 2×NAG; 1×NAG; 2×ABU; 2×NAG; 1×MAN; | ||||
Assess | ||||||
Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus etomidate |
Heteromer P14867; P18507; | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 2×V8D; | ||||
Assess | ||||||
Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus DMCM |
Heteromer P14867; P18507; | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 3×R63; | ||||
Assess | ||||||
Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus dehydroepiandrosterone s… |
Heteromer P14867; P18507; | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 1×ZWY; 6×PTY; 1×Q3G; 1×POV; | ||||
Assess | ||||||
Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus propofol |
Heteromer P14867; P18507; | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 2×PFL; | ||||
Assess | ||||||
Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus picrotoxin |
Heteromer P14867; P18507; | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 1×RI5; | ||||
Assess | ||||||
Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus diazepam |
Heteromer P14867; P18507; | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 4×DZP; | ||||
Assess | ||||||
Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with bicuculline methbromide |
Heteromer P14867; P18507; | 2×NAG; 1×NAG; 1×NAG; 3×NAG; 2×J94; 1×MAN; | ||||
Assess | ||||||
Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA |
Heteromer P14867; P18507; | 2×NAG; 1×NAG; 1×NAG; 3×NAG; 2×ABU; | ||||
Assess | ||||||
Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus phenobarbital |
Heteromer P14867; P18507; | 2×NAG; 1×NAG; 1×NAG; 3×NAG; 2×ABU; 2×UQA; | ||||
Assess | ||||||
Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus flumazenil |
Heteromer P14867; P18507; | 2×NAG; 1×NAG; 1×NAG; 3×NAG; 2×ABU; 1×FYP; | ||||
Assess | ||||||
Human GABA-A receptor alpha1-beta2-gamma2 subtype in complex with GABA and flumazenil, conformation… |
Heteromer P14867; P18507; | 2×NAG; 1×NAG; 1×NAG; 3×NAG; 2×ABU; 12×Y01; 1×FYP; | ||||
Assess | ||||||
Human GABA-A receptor alpha1-beta2-gamma2 subtype in complex with GABA and flumazenil, conformation… |
Heteromer P14867; P18507; | 2×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 12×Y01; 1×FYP; | ||||
Assess |
1 SWISS-MODEL model
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
8foi.1.E | monomer | 0.62 | 1×NAG; 4×D12; 3×OCT; | 99.41 | ||
Assess |
3 SWISS-MODEL models built on isoform sequence
Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
---|---|---|---|---|---|---|
Isoform 1 | 8foi.1.E | monomer | 0.67 | 1×NAG; 4×D12; 3×OCT; | 99.79 | |
Assess | ||||||
Isoform 3 | 7qne.1.E | monomer | 0.85 | 87.06 | ||
Assess | ||||||
Isoform 4 | 8foi.1.E | monomer | 0.87 | 2×OCT; | 99.46 | |
Assess |